Navigation Links
Press Statement Issued by Ranbaxy Laboratories Limited
Date:2/25/2009

GURGAON, India, Feb. 25 /PRNewswire/ -- Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxy's Paonta Sahib facility have been added to a list maintained under a policy entitled "Application Integrity Policy" or "AIP". Ranbaxy will analyze the letter and other information fully and respond appropriately in a timely manner.

The FDA has said it has no evidence the drugs on the market are substandard and also that they comply with specifications upon testing.

No products from Ranbaxy's other manufacturing facilities are included in the AIP.

Ranbaxy will continue to co-operate with the USFDA. Further, no effort or action will be spared to timely protect key ANDAs from Paonta Sahib, which include some First to File applications.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies," resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 11 countries.

    Company Contacts for Media:

    India Contacts:

    Ramesh L. Adige
    President - Corporate Affairs and Global Corporate Communications
    Ranbaxy Laboratories Ltd.
    Plot 90, Sector 32, Gurgaon
    Haryana122001, India
    Tel: +91-124-4135000
    e-mail: ramesh.adige@ranbaxy.com

    or

    Raghu Kochar
    Director - Corporate Communications
    Ranbaxy Laboratories Ltd.
    Plot 90, Sector 32, Gurgaon
    Haryana122001, India
    Tel: +91-124-4135141 / Mob: 9811617256
    e-mail: raghu.kochar@ranbaxy.com

    or

    Krishnan Ramalingam
    Sr. Manager - Corporate Communications
    Ranbaxy Laboratories Ltd.
    Plot 90, Sector 32, Gurgaon
    Haryana122001, India
    Tel: +91-124-4135143 / Mob: 9810042540
    e-mail: krishnan.ramalingam@ranbaxy.com

    USA Contact:

    Charles M. Caprariello
    Vice President, Corporate Communications
    Ranbaxy Inc.
    (609) 720-5615
    email : chuck.caprariello@ranbaxy.com


'/>"/>
SOURCE Ranbaxy Laboratories Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. Clinical depression linked to abnormal emotional brain circuits
4. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
5. Specific antagonism lowers blood pressure
6. Are too many people diagnosed as depressed?
7. Depression Taking Toll on Returning U.S. Vets
8. Doctors Often Miss High Blood Pressure in Kids
9. Pill box organizers increase HIV patients adherence and improve viral suppression
10. Damp, Moldy Homes May Cause Depression
11. Treating depression may improve recovery of heart rate variability following coronary syndromes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 18, 2017 , ... Paragon and ... to help the cannabis industry move towards greater legitimacy. By incorporating IOTA’s unique ... technology with lower fees. Paragon will build a fully verifiable database to track ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press ... mothers. These illustrations show the diversity of the breastfeeding mothers, using bright ... range of sizes. These illustrations are also available on tote bags, notepads, smartphone ...
(Date:8/19/2017)... , ... August 19, 2017 , ... “Congratulations! It's A ... of children to both their parents and God. “Congratulations! It's A Boy! God’s Gift: ... Anthony, a couple from Long Island, New York. , Published by Christian Faith Publishing, ...
(Date:8/18/2017)... New York (PRWEB) , ... ... ... Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light logistics ... it has entered into a definitive agreement to purchase Unitrans International Corporation, ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... handheld devices. Through an educational webinar, they will present the line of epMotion ... to learn how easy you can automate everyday pipetting tasks. , Ideal for ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... N.C. , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator ... rumored to be in the beginning stages of an IPO. ... on epilepsy medications with the average cost of a prescription epilepsy drug ... ... Another staggering figure is the fact ...
(Date:8/11/2017)... , Aug. 11, 2017 DarioHealth Corp. ... mobile health and big data solutions, today announced that ... Monday, August 14 and host a conference call at ... 2017 operating and financial results and its strategy and ... be hosted by Erez Raphael , Chief Executive ...
(Date:8/7/2017)... GAITHERSBURG, Md. , Aug. 7, 2017 /PRNewswire/ ... for healthcare member acquisition, retention, and engagement, announced ... Director of Strategy and Product Development, effective as ... strategic consulting and technology implementation strategy for our ... years of experience in consulting and business analytics ...
Breaking Medicine Technology: